UP5-60153-77394
3 vaccinations
1 coded response
2 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 601 / IL
- Registered
- 2022-02-09
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-06-24
Dose 1 — Pfizer-BioNTech
-
2021-07-07
Dose 2 — Pfizer-BioNTech
-
2022-02-08
Dose 3 — Pfizer-BioNTech
-
2022-02-09
Registered in v-safe
-
2022-02-09
Survey response — days 1–6 daily, dose 3MedDRA: Ear pain, Pain in jaw — Feeling: Poor · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Ear and jaw painMedDRA releases: 2024-11 · check-in free text available
-
2022-02-10
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness, NauseaAdult check-in
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-06-24 | Pfizer-BioNTech | No |
| 2 | 2021-07-07 | Pfizer-BioNTech | No |
| 3 | 2022-02-08 | Pfizer-BioNTech | No |
Free text
Release 11 — days 1–6 daily, dose 3
Systemic reaction (other): Ear and jaw pain
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Ear pain | · | · | ✓ |
| SRO | Pain in jaw | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release